Ro

Based in New York, US, and founded in 2017, Roman Health Ventures Inc. , dba Ro operates as a healthcare technology company. The company was co-founded by Zachariah Reitano (CEO), Rob Schutz, and Saman Rahmanian. In February 2022, Roman Health Ventures Inc.

raised USD 100 million in series D funding led by ShawSpring Partners, with participation from General Catalyst Partners, FirstMark Capital, TQ Ventures, SignalFire, BoxGroup, TCG, Initialized Capital, Altimeter Capital Management, Baupost Group, and 776. The series D funding values Roman Health Ventures Inc. at USD 6. 66 billion post-money.

Ro is a provider of digital health platforms including Roman for men and Rory for women that enables physicians, nurses, and pharmacists to track their journey with Ro's platform, and facilitates care coordination between providers to provide delivery of medication, to ongoing care. The company also offers a health guide, workpath, weight management, and zero providing treatment to help with smoking cessation. The company generates revenue through its direct-to-consumer telehealth platform, offering virtual consultations, personalized treatment plans, and integrated pharmacy services. Patients pay out-of-pocket for services like men's and women's health, weight management, mental health, and skincare.

Ro also earns from its proprietary technology platform, employer partnerships, and recurring medication deliveries. The company plans to use the funding from February 2022 to speed up the integration of its services, expand its offerings including the introduction of its online and mobile platforms.